Your shopping cart is currently empty

BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $81 | In Stock | In Stock | |
| 5 mg | $163 | In Stock | In Stock | |
| 10 mg | $243 | - | In Stock | |
| 25 mg | $397 | - | In Stock | |
| 50 mg | $598 | - | In Stock |
| Description | BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases. |
| Targets&IC50 | BTK:1.1 nM, TEC:99 nM, EGFR:621 nM |
| In vivo | In 9-week-old female NOD/SCID mice harboring REC-1 MCL xenografts, BGB-8035 (administered at doses of 7.5, 15, and 30 mg/kg; oral dosing; twice daily) exhibited dose-dependent antitumor activity, with corresponding Tumor Growth Inhibition (TGI) values of 64.1%, 73.6%, and 79.9%, respectively[1]. |
| Synonyms | BGB8035, BGB 8035 |
| Molecular Weight | 453.53 |
| Formula | C24H31N5O4 |
| Cas No. | 2283349-24-4 |
| Smiles | C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.